Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
In Silico and In Vitro Evaluation of Bevacizumab Biosimilar MB02 as an Antitumor Agent in Canine Mammary Carcinoma.
Animals (Basel). 2023 Aug 3;13(15):2507. doi: 10.3390/ani13152507.
Animals (Basel). 2023.
PMID: 37570315
Free PMC article.
Current state and comparison of the clinical development of bevacizumab, rituximab and trastuzumab biosimilars.
Díaz LP, Millán S, Chaban N, Campo AD, Spitzer E.
Díaz LP, et al.
Future Oncol. 2021 Jul;17(19):2529-2544. doi: 10.2217/fon-2020-0923. Epub 2021 Apr 27.
Future Oncol. 2021.
PMID: 33904318
Free article.
Review.
Item in Clipboard
Cite
Cite